Jacqueminet S - Search Results

1

Percutaneous transluminal angioplasty in severe diabetic foot ischemia: outcomes and prognostic factors.

Jacqueminet S, Hartemann-Heurtier A, Izzillo R, Cluzel P, Golmard JL, Ha Van G, Koskas F, Grimaldi A. Jacqueminet S, et al. Diabetes Metab. 2005 Sep;31(4 Pt 1):370-5. doi: 10.1016/s1262-3636(07)70206-9. Diabetes Metab. 2005. PMID: 16369199

2

Outcome of severe diabetic foot ulcers after standardised management in a specialised unit.

Hartemann-Heurtier A, Ha Van G, Danan JP, Koskas F, Jacqueminet S, Golmard JL, Grimaldi A. Hartemann-Heurtier A, et al. Among authors: jacqueminet s. Diabetes Metab. 2002 Dec;28(6 Pt 1):477-84. Diabetes Metab. 2002. PMID: 12522328

3

Nonremovable, windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance.

Ha Van G, Siney H, Hartmann-Heurtier A, Jacqueminet S, Greau F, Grimaldi A. Ha Van G, et al. Among authors: jacqueminet s. Diabetes Care. 2003 Oct;26(10):2848-52. doi: 10.2337/diacare.26.10.2848. Diabetes Care. 2003. PMID: 14514590 Clinical Trial.

4

Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact.

Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard JL, Jarlier V, Grimaldi A. Hartemann-Heurtier A, et al. Among authors: jacqueminet s. Diabet Med. 2004 Jul;21(7):710-5. doi: 10.1111/j.1464-5491.2004.01237.x. Diabet Med. 2004. PMID: 15209763

5

Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.

Nobécourt E, Jacqueminet S, Hansel B, Chantepie S, Grimaldi A, Chapman MJ, Kontush A. Nobécourt E, et al. Among authors: jacqueminet s. Diabetologia. 2005 Mar;48(3):529-38. doi: 10.1007/s00125-004-1655-5. Epub 2005 Feb 24. Diabetologia. 2005. PMID: 15729582

6

Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes.

Challier M, Jacqueminet S, Benabdesselam O, Grimaldi A, Beaudeux JL. Challier M, et al. Among authors: jacqueminet s. Clin Chem. 2005 Sep;51(9):1749-50. doi: 10.1373/clinchem.2005.051961. Clin Chem. 2005. PMID: 16120960 No abstract available.

7

Limitations of the so-called "intensified" insulin therapy in type 1 diabetes mellitus.

Jacqueminet S, Masseboeuf N, Rolland M, Grimaldi A, Sachon C. Jacqueminet S, et al. Diabetes Metab. 2005 Sep;31(4 Pt 2):4S45-4S50. doi: 10.1016/s1262-3636(05)88267-9. Diabetes Metab. 2005. PMID: 16389898 Review.

8

Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.

Jacqueminet S, Ben Abdesselam O, Chapman MJ, Nicolay N, Foglietti MJ, Grimaldi A, Beaudeux JL. Jacqueminet S, et al. Clin Chim Acta. 2006 May;367(1-2):103-7. doi: 10.1016/j.cca.2005.11.029. Epub 2006 Jan 19. Clin Chim Acta. 2006. PMID: 16426593

9

Should diabetic patients be asked to test their blood glucose 90 to 120 minutes after the beginning of their meals?

Sachon C, Jacqueminet S, Hartemann-Heurtier A, Grimaldi A. Sachon C, et al. Among authors: jacqueminet s. Diabetes Metab. 2006 Sep;32(4):377-81. doi: 10.1016/s1262-3636(07)70295-1. Diabetes Metab. 2006. PMID: 16977268

10

Insulin therapy for type 2 diabetes: premixed or basal-prandial?

Halbron M, Jacqueminet S, Sachon C, Bosquet F, Hartemann-Heurtier A, Grimaldi A. Halbron M, et al. Among authors: jacqueminet s. Diabetes Metab. 2007 Sep;33(4):316-20. doi: 10.1016/j.diabet.2007.01.005. Epub 2007 Apr 26. Diabetes Metab. 2007. PMID: 17466560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters